New study on the safety and side effects of cannabidiol (CBD)

The European Industrial Hemp Association (EIHA) has commissioned a new study on the safety and side effects of cannabidiol. Kerstin Iffland and Dr. med. Franjo Grothenhermen look at clinical studies and possible interactions with other medications. The work is an update of the detailed study by Bergamaschi and colleagues from 2011. Currently only an English version is available.

This post was translated from DeepL.